27.90 USD
▲+1.19+4.46%
盘后 27.92 +0.07%
2026-09-15
市值
$1.80B
市盈率
2.64
EPS
10.34
股息率
—
52 周区间
25.68 – 37.78
成交量
890.38K
Beta
0.12
目标价
23.75
52W 低 25.6852W 高 37.78
价格走势
公司简介
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relaps...